EPIC-B: phase II trial of cemiplimab as first-line treatment in advanced penile carcinoma

Item

EPIC-B: phase II trial of cemiplimab as first-line treatment in advanced penile carcinoma

Challapalli, A.
;
Bahl, A.
;
Venugopal, B.
;
Afshar, M.
;
Alifrangis, C.
;
Thomson, A.
;
Tran, A.
;
Hudson, A.
;
Kent, C.
;
Barber, J.
... show 7 more

Citations

Google Scholar:

Altmetric:

Authors

Challapalli, A.
Bahl, A.
Venugopal, B.
Afshar, M.
Alifrangis, C.
Thomson, A.
Tran, A.
Hudson, A.
Kent, C.
Barber, J.
Dearden, H. C.
Pearson, R.
Kumar, V.
Wade, R.
Bravo, A.
White, P.
Foulstone, E.

Affiliation

Univ Hosp Bristol & Weston NHS Fdn Trust, Bristol Haematol & Oncol Ctr, Bristol, England Beatson West Scotland Canc Ctr, Glasgow, Scotland St Georges Univ Hosp NHS FT, London, England Univ Coll London Hosp NHS Fdn Trust, London, England Royal Cornwall Hosp NHS Trust, Truro, England Christie NHS Fdn Trust, Manchester, England Univ Hosp Leicester NHS Trust, Leicester Royal Infirm, Leicester, England Velindre Univ NHS Trust, Cardiff, Wales Leeds Teaching Hosp NHS trust, Leeds, England Northern Ctr Canc Care NCCC, Newcastle Upon Tyne, England Norfolk & Norwich Univ Hosp, Norwich, England Univ West England, Bristol, England

Date

2025

Collections

All Christie Publications

Show all metadata

Type

Meetings and Proceedings

Citation

Challapalli A, Bahl A, Venugopal B, Afshar M, Alifrangis C, Thomson A, et al. EPIC-B: Phase II trial of cemiplimab as first-line treatment in advanced penile carcinoma. JOURNAL OF CLINICAL ONCOLOGY. 2025 FEB 10;43(5_SUPPL). PubMed PMID: WOS:001454740300014. English.

URI

https://christie.openrepository.com/handle/10541/627703